These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23206860)

  • 21. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Boyer J; Arnoult E; Médebielle M; Guillemont J; Unge J; Jochmans D
    J Med Chem; 2011 Dec; 54(23):7974-85. PubMed ID: 22017513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of anti-HIV-1 and anti-HSV-1 activities of 4H-[1,2,4]-triazolo[1,5-a]pyrimidin-5-one derivatives.
    Abdel-Hafez AA; Elsherief HA; Jo M; Kurokawa M; Shiraki K; Kawahata T; Otake T; Nakamura N; Hattori M
    Arzneimittelforschung; 2002; 52(11):833-9. PubMed ID: 12489255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
    Gu SX; Yang SQ; He QQ; Ma XD; Chen FE; Dai HF; Clercq ED; Balzarini J; Pannecouque C
    Bioorg Med Chem; 2011 Dec; 19(23):7093-9. PubMed ID: 22037050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents.
    Mizuhara T; Oishi S; Ohno H; Shimura K; Matsuoka M; Fujii N
    Bioorg Med Chem; 2012 Nov; 20(21):6434-41. PubMed ID: 23022280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
    Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA
    J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.
    Wang Z; Wang M; Yao X; Li Y; Qiao W; Geng Y; Liu Y; Wang Q
    Eur J Med Chem; 2012 Apr; 50():361-9. PubMed ID: 22369862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
    Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
    J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.
    Turpin JA; Song Y; Inman JK; Huang M; Wallqvist A; Maynard A; Covell DG; Rice WG; Appella E
    J Med Chem; 1999 Jan; 42(1):67-86. PubMed ID: 9888834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-HIV activity of different novel nonclassical nucleosides.
    Elgemeie GE; Mansour OA; Metwally NH
    Nucleosides Nucleotides; 1999 Jan; 18(1):113-23. PubMed ID: 10048227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel MKC-442 analogues with potent activities against HIV-1.
    El-Brollosy NR; Pedersen EB; Nielsen C
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):236-41. PubMed ID: 12916058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of the biotinylated anti-HIV compound BMMP and the target identification study.
    Kamo M; Tateishi H; Koga R; Okamoto Y; Otsuka M; Fujita M
    Bioorg Med Chem Lett; 2016 Jan; 26(1):43-5. PubMed ID: 26615887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses.
    Tang G; Kertesz DJ; Yang M; Lin X; Wang Z; Li W; Qiu Z; Chen J; Mei J; Chen L; Mirzadegan T; Harris SF; Villaseñor AG; Fretland J; Fitch WL; Hang JQ; Heilek G; Klumpp K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6020-3. PubMed ID: 20829038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1802-6. PubMed ID: 19217781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): modification of the acyl portion.
    Duan M; Peckham J; Edelstein M; Ferris R; Kazmierski WM; Spaltenstein A; Wheelan P; Xiong Z
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7401-4. PubMed ID: 21055933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Wang Z; Wu B; Kuhen KL; Bursulaya B; Nguyen TN; Nguyen DG; He Y
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4174-7. PubMed ID: 16781149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
    Fujiwara N; Nakajima T; Ueda Y; Fujita H; Kawakami H
    Bioorg Med Chem; 2008 Nov; 16(22):9804-16. PubMed ID: 18926711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
    Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
    J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.
    Guillemont J; Pasquier E; Palandjian P; Vernier D; Gaurrand S; Lewi PJ; Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers MH; Arnold E; Das K; Pauwels R; Andries K; de Béthune MP; Bettens E; Hertogs K; Wigerinck P; Timmerman P; Janssen PA
    J Med Chem; 2005 Mar; 48(6):2072-9. PubMed ID: 15771449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural modifications of DAPY analogues with potent anti-HIV-1 activity.
    Feng XQ; Liang YH; Zeng ZS; Chen FE; Balzarini J; Pannecouque C; De Clercq E
    ChemMedChem; 2009 Feb; 4(2):219-24. PubMed ID: 19090525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.